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There are four serotypes of Dengue virus and there are existing drugs used against specific serotype. 
There is no drug that is effective against all strains of this virus. In this research, bioinformatics tools 
were used to predict the affinity of natural ligands for the glycoprotein E of Dengue virus by 
considering the conserved domains. Molecular docking studies were carried out by using Autodock 3.0. 
Computational analysis which showed that two ligands have the potential to inhibit the site in 
glycoprotein E and control of all strains is now possible by these ligands. 
 






The use of computers and computational methods 
saturate all aspects of drug discovery today and forms 
the core of structure-based drug design (Kapetanovic, 
2008). In silico methods can help in identifying drug 
targets through bioinformatics tools. They can also be 
used to evaluate target structures for possible binding/ 
active sites, to generate candidate molecules and check 
for their drug-like properties. In addition, such methods 
can be used to dock these molecules with the target, rank 
them according to their binding affinities and further 
optimize the molecules to improve binding charac-
teristics. 
Dengue virus is a member of Flaviviridae family. Four 
strains of Dengue strains were designated as DEN-1, 
DEN-2, DEN-3 and DEN-4, and infection by any one 
serotype leaves individuals susceptible to infection by the 
remaining three serotypes. This disease cannot be 
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Dengue  viruses  have  60  to  80%  homology  to  each 
other. The basic difference is on structural basis that is 
also associated with the pathogenecity. Phylogenetic 
relationship of Dengue strains show that DEN-1 and 
DEN-3 are closely related (Qil and Chil, 2008). During 
Dengue virus intracellular development, the viral pre-
cursor membrane (prM) matures in the last step of virion 
assembly, most probably to avoid catastrophic activation 
of the viral fusion peptide induced by the acidic pH of the 
trans-Golgi network. Envelop E protein contains class 2 
fusion peptide sequences that are responsible for 
invasion of attachment to host cell (Modis et al., 2004). 
In the acid conditions during endocytosis in endosome, 
the E proteins undergo a dramatic structural change from 
dimmer into trimmer. These trimmers lead to formation of 




MATERIALS AND METHODS 
 
Protein sequences of E-protein of all four strains were obtained 
from the Viral Zone (http://www.expasy.ch/viralzone/) and were 
submitted to Clustal W, available at www.ebi.ac.uk/clustalw/-21k. 
Identified highly conserved  regions  in  all  strains  within  prefusion  
 
 




Table 1. Conserved sequences in 4 serotypes of dengue of 
envelop protein 
 
Conserved sequence Position 
MRC 1 - 3 
G  5 
NRDFVEG 8 - 14 
SG 16,17 
VLEHG 24  - 28 
CVTTMA 30 - 35 
KPTLDFEL 38 - 45 
CIE 60 - 62 
N 67 
TT 69,70 
RCPTQGE 73 - 79 








QWF 211 - 213 
DLPLPW 215 - 220 
VLGSQEGAMH 252 - 261 
ALTGATE 263 - 269 
ETQHGT 314 - 319 




protein E, were then confirmed by T-Coffee 7.44. Some of the 
conserved amino acids are postulated to form a contour that can be 
used as the potential drug target and are mentioned in Table 1. 
 
 
Identification of domains  
 
Dengue virus protein E contains 3 domains that mainly consist of 
beta sheets. Domain 2 contains a loop at its tip with a hydrophobic 
sequence that is conserved among all flaviviruses. This loop ranges 
from 97 to 111 amino acids. The image of these amino acids from 
the Python Molecule Viewer (PMV 1.5.2) is given in Figure 1. 
 
 
Fusion loop of sE protein 
 
Three hydrophobic residues in the fusion loop conserved among all 
the flavivirus–Trp 101, Leu 107 and Phe 108 (Figure 2a and b). 
This fusion loop maintains the same structure in both the dimeric 
and trimeric form. So, this loop is considered as drug target in this 
study because fruitful results of drug binding can be helpful in 
controlling this fatal disease caused by any of the strain of Dengue 
just by a single drug. As Trp 101, Leu 107 and Phe 108 are highly 
conserved within all strains, they ensure the validity of selection of 





Calculation of hydrophobicity 
 






Using the scale Hphob/Kyte and Doolittle, the individual values for 
the 20 amino acids are:  
 
Ala:  1.800; Arg: -4.500; Asn: -3.500; Asp: -3.500; Cys: 2.500; Gln: 
3.500; Glu: -3.500; Gly: -0.400; His: -3.200; Ile: 4.500; Leu: 3.800; 
Lys: -3.900; Met: 1.900;  Phe: 2.800; Pro: -1.600; Ser: -0.800; Thr: -
0.700; Trp: -0.900; Tyr: -1.300; Val:  4.200, -3.500, -3.500 and -
0.490.   
 
Weights for window positions 1... 9, using linear weight variation 
model: 
 
   1         2        3        4        5       6         7       8         9     
 1.00   1.00   1.00   1.00    1.00   1.00   1.00   1.00   1.00  





Figure 3 shows areas that are more hydrophobic, predicted by 
these calculations. According to PMV 1.5.2, there are 6296 atoms, 
844 residues and 4 chains in E- protein. Two conserved N-linked 
glycosylation sites are Asn-67 and Asn-153. Asn-153 is conserved 
in most flavivirus, while site of Asn-67 is unique in type-3 virus. 
These two sites are involved in cellular attachment and viral entry 





Potential ligands were chosen from natural compounds that have 
been extracted from Citrus limonia by Doctor Waseem Akram, 
Department of Agriantamology, University of Agriculture, Faislabad. 
Two of such candidate molecules are nomilin and limonin. 
 
 
Drug characteristics of nomilin and limonin 
 
Table 2 shows the properties of both nomilin and limonin. The 
chemical structures for the test ligands “limonin” and “nomilin” were 
taken from the PubChem (http://pubchem.ncbi.nlm.nih.gov/). Atoms 
in nomilin and limonin are shown in figures taken from The Dundee 





Amino acids 97 through 111 are conserved in all strains and are 





Autodock 3 was used to provide modeling flexible ligand binding to 
the rigid receptor. Minimum energy for nomilin -7.27 kcal/mol with 
40 clusters and the root mean square deviation (RMSD) = 0.00. 
 
Final intermolecular energy = -6.92 kcal/mol 
Final internal energy of ligand = -0.35 kcal/mol 
 
 












Figure 2.  (a) Hydrophobic areas in 1OAN.pdb (Trp 101, Leu 107 and Phe 108). (b) Hydrophobic 
areas in 1OAN.pdb (Representation of area where Trp 101, Leu 107 and Phe 108 are present). 
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Table 2.  Physicochemical properties of limonin and nomilin. 
 
Physical property Limonin Nomilin 
Molecular weight 470.5116 [g/mol] 514.56416 [g/mol] 
Molecular formula C26H30O8 C28H34O9 
XLogP3-AA 1.8 2.6 
H-Bond donor 0 0 
H-Bond acceptor 8 9 
Rotatable bond count 1 3 
Tautomer count 2 2 
Exact mass 470.194068 514.220283 
MonoIsotopic mass 470.194068 514.220283 
Polar surface area 105 122 
Heavy atom count 34 37 
Formal charge 0 0 
Complexity 1010 1080 
Isotope atom count 0 0 
Defined atom stereo center count 8 0 
Undefined atom stereo center count 1 9 
Defined bond stereo center count 0 0 
Undefined bond stereo center count 0 0 
Covalently-bonded unit count 1 1 
 
 











Nomilin showed docking with amino acids ARG 99 and GLY 102 
(Figure 4). Hydrogen bond formed: OAH atom of nomilin and Arg-
99; OAI atom of nomilin and Gly-102.  
The best and lowest docking energy of limonin that is equal to -
6.83 kcal/mol and having number of clusters = 6 was obtained. 
PyMOL shows interaction of Limonin with Gly-109 (Figure 5). In 
ADT 3.05, the hydrogen bond formed is between OAD atom of 
limonin and Arg-99 (Figure 6). 
 
 
Calculations of absorption, distribution, metabolism and 
excretion (ADME) property of ligands 
 
Potential drug ADME properties of limonin and nomilin were 
calculated by web based tool cLogP (http://www.organic-
chemistry.org/prog/). ADME property of limonin shows: 
 
No risk of mutagenicity, score 1.0 
No risk of tumorigenicity, score 1.0 
No risk of irritating effects, score 1.0 
No risk of reproductive effects, score 1.0 
 
These results are the combined results of the cLogP, solubility, 
drug likeliness and drug score. 
 
ADME property of nomilin shows: 
 
No risk of mutagenicity, score 1.0 
No risk of tumorigenicity, score 1.0 
No risk of irritating effects, score 1.0 
No risk of reproductive effects, score 1.0 
 
These results are the combined results of the cLogP, solubility, 
drug likeliness, and drug score. These ADME calculations indicate 






According to World Health Organization, 50 million 
human victims for Dengue virus have been reported. So, 
it has become a challenge to develop some treatment for 
this disease because it has proven difficult to control 
mosquito borne diseases. To develop a tetravalent potent 
drug or vaccine, it is always an indispensable demand to 
treat this disease that is caused by 4 serotypes with 
different level of severity. Scientists succeeded in 
developing tetravalent vaccines but because of meddling 
of different attenuated Dengue virus, they need to be 
improved (Edelman et al., 2003). Identification of 
inhibitors of antiflavivirus opened horizons for the deve-
lopment of antidengue drug development. The target of 
these drugs can be any of the viral stage to inhibit its 
spread in the body but again the drug should be 
tetravalent. Therefore, nucleic acid based therapy was 
developed to inhibit replication of virus in the cell but it 
was able to control DEN-2 strain only (Adleman et al., 
2002). Similarly, viral entry inhibitor compounds have 
been discovered, some of which are specific to stop only 
DEN-3 and to a lesser degree DEN-1 and DEN-4 (Ono et 
al., 2006). In this study, efforts have been made to 
develop a tetravalent drug. To accomplish the goal, 
envelop protein is selected as a target for drug because it 
is the first one that enters the cells by binding and hence 
begins the surge of infection. Moreover, the target site 
that is selected consists of amino acid sequence that is 
conserved in all the strains. So, selection of such a target  
 
 
















site is important for entry into the body cells and is 
present in all strains of Dengue virus which is a key for 
developing a tetravalent drug.  The  ligands  selected  are  
from C. limonia which also showed good binding to the 
target site. This binding affinity shows that these ligands 












Selection of conserved site as drug target is of core 
importance in focusing the problem of designing a multi-
variant drug against all serotypes of dengue. Selection of 
conserved regions among all the serotypes has played 
the leading role to select such ligands that can prevent 
the infection from prevailing from the very beginning 
when the Dengue virus enters the body and the envelop 
protein get attached to the DC cells of the body. Natural 
ligands are considered because of their surety of been 
non-toxic to humans. Computational analysis showed 
that two ligands have the potential to inhibit that site in 
glycoprotein E that is conserved among 4 strains. When 
the ligand get attached to the fusion peptide of the 
envelop protein, it does not allow the protein to transform 
into tripeptide. This tripeptide binds to the body cells and 
is important for causing infection. So, in this way, the 
drug performs its function.  Based on the results of Auto-
dock 3 and ADME properties, it can be concluded that 
these two ligands can be proved as the best weapon to 
stop the infection of Dengue virus from spreading in 
humans. So, it can be hypothesized that these ligands 
may be found to be effective if tested in wet laboratory. 
Moreover, identification of various conserved sites can 
preferentially be used as drug targets or to induce 
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